MSB 1.29% $1.18 mesoblast limited

Crohn’s Disease, page-110

  1. 7,779 Posts.
    lightbulb Created with Sketch. 1337
    Don't really know what your point is Reg, just because I'm not a holder doesn't mean I'm not interested. I wouldn't be surprised if I've done a bit more research into the company than many LTHers here (and I've been keeping up with it for a few years now).

    I'm also following these trials. It's still too early to definitively tell if the therapy works, that's my stance. And it's a valid stance.

    If the whole trial of 48 or whatever people goes through and continues to show similar success, I'll be impressed and I'll say as much. And I may even pick up a parcel myself.

    I'm most interested in seeing the results of the control groups being swapped and treated with MSCs, as if they then go on to achieve remission that's another impressive result, and strongly favours the cells having an effect.

    I'm intrigued and hopeful as well. And I'm very happy for you to ignore me, if you don't like to think about opposing opinions.
    Last edited by DocMcstuffins: 20/05/22
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.18
Change
0.015(1.29%)
Mkt cap ! $1.347B
Open High Low Value Volume
$1.15 $1.20 $1.15 $4.551M 3.886M

Buyers (Bids)

No. Vol. Price($)
2 98246 $1.17
 

Sellers (Offers)

Price($) Vol. No.
$1.18 19079 2
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.